| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.
|
JAMA
|
2005
|
4.60
|
|
2
|
Left atrial appendage: an underrecognized trigger site of atrial fibrillation.
|
Circulation
|
2010
|
2.56
|
|
3
|
Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study.
|
Heart Rhythm
|
2009
|
2.30
|
|
4
|
Venice Chart international consensus document on atrial fibrillation ablation.
|
J Cardiovasc Electrophysiol
|
2007
|
2.25
|
|
5
|
[GISE/AIAC position paper on percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: recommendations for patient selection, facilities, competences, organizing and training requirements].
|
G Ital Cardiol (Rome)
|
2014
|
1.98
|
|
6
|
Phrenic nerve injury after catheter ablation: should we worry about this complication?
|
J Cardiovasc Electrophysiol
|
2006
|
1.83
|
|
7
|
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.
|
N Engl J Med
|
2008
|
1.65
|
|
8
|
Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
|
Circulation
|
2010
|
1.64
|
|
9
|
Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians.
|
J Cardiovasc Electrophysiol
|
2008
|
1.59
|
|
10
|
Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL).
|
Circulation
|
2013
|
1.48
|
|
11
|
Ablation of perimitral flutter following catheter ablation of atrial fibrillation: impact on outcomes from a randomized study (PROPOSE).
|
J Cardiovasc Electrophysiol
|
2011
|
1.44
|
|
12
|
Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.
|
J Am Coll Cardiol
|
2004
|
1.33
|
|
13
|
Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy.
|
Circulation
|
2003
|
1.32
|
|
14
|
Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study.
|
J Cardiovasc Electrophysiol
|
2009
|
1.20
|
|
15
|
Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques.
|
Circ Arrhythm Electrophysiol
|
2009
|
1.16
|
|
16
|
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.
|
Europace
|
2013
|
1.16
|
|
17
|
Venice Chart international consensus document on atrial fibrillation ablation: 2011 update.
|
J Cardiovasc Electrophysiol
|
2012
|
1.16
|
|
18
|
Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging.
|
J Cardiovasc Electrophysiol
|
2005
|
1.15
|
|
19
|
Visually-guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome.
|
Circulation
|
2009
|
1.04
|
|
20
|
Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation.
|
J Cardiovasc Electrophysiol
|
2010
|
1.00
|
|
21
|
Rationale and current perspective for early rhythm control therapy in atrial fibrillation.
|
Europace
|
2011
|
0.87
|
|
22
|
Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study.
|
Heart Rhythm
|
2012
|
0.84
|
|
23
|
Anatomic location of pulmonary vein electrical disconnection with balloon-based catheter ablation.
|
J Cardiovasc Electrophysiol
|
2007
|
0.84
|
|
24
|
Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2013
|
0.83
|
|
25
|
Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
|
Pacing Clin Electrophysiol
|
2004
|
0.82
|
|
26
|
Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
|
Heart Rhythm
|
2006
|
0.82
|
|
27
|
A randomized controlled trial of the efficacy and safety of electroanatomic circumferential pulmonary vein ablation supplemented by ablation of complex fractionated atrial electrograms versus potential-guided pulmonary vein antrum isolation guided by intracardiac ultrasound.
|
Circ Arrhythm Electrophysiol
|
2009
|
0.82
|
|
28
|
Intracardiac echocardiography for implantation of LAA occlusion devices: a further step toward the ICE era?
|
Heart Rhythm
|
2007
|
0.81
|
|
29
|
Role of anticoagulation therapy after pulmonary vein antrum isolation for atrial fibrillation treatment.
|
J Cardiovasc Med (Hagerstown)
|
2008
|
0.80
|
|
30
|
The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial.
|
Eur Heart J
|
2015
|
0.80
|
|
31
|
Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
|
J Am Coll Cardiol
|
2004
|
0.79
|
|
32
|
Novel ICE-guided registration strategy for integration of electroanatomical mapping with three-dimensional CT/MR images to guide catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2008
|
0.79
|
|
33
|
Role of transoesophageal echocardiography in evaluating the effect of catheter ablation of atrial fibrillation on anatomy and function of the pulmonary veins.
|
Europace
|
2008
|
0.77
|
|
34
|
Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.77
|
|
35
|
Adherence to guidelines for atrial fibrillation management of patients referred to cardiology departments: Studio Italiano multicentrico sul Trattamento della Fibrillazione Atriale (SITAF).
|
Europace
|
2010
|
0.76
|
|
36
|
Novel oral anticoagulants in the electrophysiology lab: are we really ready to forget warfarin?
|
Europace
|
2013
|
0.75
|
|
37
|
Iatrogenic postatrial fibrillation ablation left atrial tachycardia/flutter: how to prevent and treat it?
|
J Cardiovasc Electrophysiol
|
2005
|
0.75
|
|
38
|
[Author reply].
|
G Ital Cardiol (Rome)
|
2015
|
0.75
|
|
39
|
An integrated anatomical and electrophysiological approach to atrial fibrillation ablation.
|
J Cardiovasc Med (Hagerstown)
|
2006
|
0.75
|
|
40
|
Reply: A Prima Vista Ablation of Ventricular Tachycardia: Should We Abandon the Mapping of VT?
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
41
|
[Appropriateness criteria for the treatment of atrial fibrillation with dronedarone: practical issues. An Italian cardiologists' expert opinion].
|
G Ital Cardiol (Rome)
|
2013
|
0.75
|
|
42
|
Reply: Factors Affecting Outcomes in Left Atrial Appendage Isolation by Catheter Ablation.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
43
|
Reply: Will LAA Isolation Increase Thrombosis and Stroke When Treating Persistent and Long-Standing Persistent AF?
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
44
|
[AIAC Guidelines on the management and treatment of atrial fibrillation. Update 2013. Associazione Italiana di Aritmologia e Cardiostimolazione].
|
G Ital Cardiol (Rome)
|
2013
|
0.75
|
|
45
|
Anticoagulation Issues in Patients with AF.
|
Card Electrophysiol Clin
|
2012
|
0.75
|
|
46
|
[2010 AIAC Guidelines for the management and treatment of atrial fibrillation].
|
G Ital Cardiol (Rome)
|
2011
|
0.75
|